EDGE
Get a demo
Log In

Fresenius AG

Overview
Financials

Fresenius SE & Co. KGaA. (FRE.DE) is a European multinational healthcare provider based in Bad Homburg vor der Höhe, Germany. The company generated EUR 40.8 billion (~USD 43.6 billion) in 2022.

Fresenius operates through four business segments: Fresenius Medical Care, which offers products and services that address chronic kidney failure; Fresenius Kabi, which offers products and solutions for chronical illnesses (including biopharmaceuticals, IV fluids, etc.); Fresenius Helios, which is a leading private hospital operator in Europe; and Fresenius Vamed, a post-acute care provider that offers project management services.

Fresenius operates 90 production sites around the world , including in China, Japan, the US, Sweden, and Germany. The company’s main markets are Europe and North America, which collectively accounted for ~84% of total revenue in 2022.

Fresenius expects low to mid-single-digit revenue growth in 2023. The company has set a cost savings target of EUR 1 billion by 2025 and is also seeking to divest several non-core assets, including plans to deconsolidate Fresenius Medical Care in 2023. Fresenius targets to achieve climate-neutrality by 2040.

HQ Location:
Else-Kröner-Straße 1 Bad Homburg Vor Der Höhe DEU
Founded year:
1912
Employees:
10,000+
Extended Reality
Extended Reality
Loading...
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.